HC Wainwright & Co. Maintains Buy on Korro Bio, Raises Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has maintained a Buy rating on Korro Bio (NASDAQ:KRRO) and increased the price target from $100 to $115. This adjustment reflects a positive outlook on the company's future performance.
March 28, 2024 | 10:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Korro Bio's stock rating was maintained as Buy by HC Wainwright & Co., with the price target raised from $100 to $115, indicating a positive future outlook.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong belief in the company's future growth and performance. This can positively influence investor sentiment and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100